The first Russian industrial production of components required for the creation of mRNA vaccines against viral, bacterial infections and cancer was launched by Biosan and Biolabmix in Novosibirsk.

Biosan and Biolabmix Group launched in Novosibirsk the first industrial production of reagents, required for the creation of mRNA vaccines against viral, bacterial infections and cancer.

The company's products are supplied to leading institutes of the Russian Academy of Sciences, the Ministry of Health, Rospotrebnadzor, FMBA, as well as development institutes such as Sirius, Skolk...

The first Russian industrial production of components required for the creation of mRNA vaccines against viral, bacterial infections and cancer was launched by Biosan and Biolabmix in Novosibirsk.

The accumulated scientific and technological base allowed us to take the next step: to create a platform for the synthesis of artificial matrix ribonucleic acid - mRNA.

Vladimir Richter told what prevented Russia from creating an analog of Pfizer and Moderna vaccines

"Biosan - Biolabmix" has fully provided Russian enterprises with key components for PCR-test systems